51
|
Xue XJ, Wang YB, Lu P, Shang HF, She JX, Xia LX, Qian H, Huang WL. Synthesis and in Vitro Evaluation of 1,3,4-Thiadiazol-2-yl Urea Derivatives as Novel AChE Inhibitors. Chem Pharm Bull (Tokyo) 2014; 62:524-7. [DOI: 10.1248/cpb.c13-00964] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Xiao-jian Xue
- School of Pharmaceutical Sciences, Nanjing University of Technology
| | - Yu-bin Wang
- School of Pharmaceutical Sciences, Nanjing University of Technology
| | - Peng Lu
- School of Pharmaceutical Sciences, Nanjing University of Technology
| | - Hai-feng Shang
- School of Pharmaceutical Sciences, Nanjing University of Technology
| | - Jin-xiong She
- School of Pharmaceutical Sciences, Nanjing University of Technology
| | - Ling-xian Xia
- Centre of Drug Discovery, China Pharmaceutical University
| | - Hai Qian
- Centre of Drug Discovery, China Pharmaceutical University
| | - Wen-long Huang
- Centre of Drug Discovery, China Pharmaceutical University
| |
Collapse
|
52
|
He XM, Zhou Y, Li J, Wu SL, Jia MM, Liu MZ, Chen H, Chen K, Li SF, Wang YH, Li WY. Pharmacokinetic and pharmacodynamic properties of batifiban coadministered with antithrombin agents in Chinese healthy volunteers. JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY. MEDICAL SCIENCES = HUA ZHONG KE JI DA XUE XUE BAO. YI XUE YING DE WEN BAN = HUAZHONG KEJI DAXUE XUEBAO. YIXUE YINGDEWEN BAN 2013; 33:786-790. [PMID: 24142738 DOI: 10.1007/s11596-013-1198-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
The combined use of batifiban, a synthetic platelet GPII b/ IIIa receptor antagonist, and antithrombin agents is an attractive option for the treatment of patients with non-ST-segment elevation (NSTE) acute coronary syndrome (ACS) and those scheduled for percutaneous coronary intervention. To observe whether antithrombin agents affect the pharmacokinetic and pharmacodynamic properties of batifiban in combination therapy and optimize clinical administration dosage of batifiban, an open-label and parallel study was conducted. Thirty healthy subjects were randomly divided into three groups, which were sequentially treated with batifiban alone, or oral coadministration of clopidogrel, aspirin and UFH, or batifiban coadministered with these antithrombin agents. Blood samples were collected at pre-specified time points. The evaluation index included the inhibition of platelet aggregation and pharmacokinetic parameters. The pharmacokinetic parameters of batifiban and batifiban coadministered with antithrombin agents showed no significant differences. The mean inhibition rate of platelet aggregation (%) suggested that neither batifiban alone nor antithrombin agents alone could provide such potent inhibition rate (>80%) to obtain the best clinical efficacy, but they had a synergistic effect on platelet inhibition. No serious adverse effects were observed. The results in these healthy subjects suggest that batifiban coadministrated with antithrombin agents could achieve optimum clinical treatment effect for patients with NSTE ACS, and also those scheduled for percutaneous coronary intervention.
Collapse
Affiliation(s)
- Xiao-Meng He
- Institute of Clinical Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Ying Zhou
- Institute of Clinical Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Jie Li
- Institute of Clinical Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - San-Lan Wu
- Institute of Clinical Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Meng-Meng Jia
- Institute of Clinical Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Ming-Zhou Liu
- Institute of Clinical Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Hui Chen
- Institute of Clinical Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Ke Chen
- Department of Infection Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | | | - Yao-Hua Wang
- Biothera Solutions Ltd., Guangzhou, 510760, China
| | - Wei-Yong Li
- Institute of Clinical Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
| |
Collapse
|
53
|
Alipour M, Khoobi M, Nadri H, Sakhteman A, Moradi A, Ghandi M, Foroumadi A, Shafiee A. Synthesis of Some New 3-Coumaranone and Coumarin Derivatives as Dual Inhibitors of Acetyl- and Butyrylcholinesterase. Arch Pharm (Weinheim) 2013; 346:577-87. [DOI: 10.1002/ardp.201300080] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2013] [Revised: 04/10/2013] [Accepted: 04/12/2013] [Indexed: 11/11/2022]
Affiliation(s)
- Masoumeh Alipour
- School of Chemistry; University College of Science, University of Tehran; Tehran; Iran
| | - Mehdi Khoobi
- Department of Medicinal Chemistry; Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences; Tehran; Iran
| | - Hamid Nadri
- Department of Medicinal Chemistry; Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences; Yazd; Iran
| | - Amirhossein Sakhteman
- Department of Medicinal Chemistry; Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences; Yazd; Iran
| | - Alireza Moradi
- Department of Medicinal Chemistry; Faculty of Pharmacy, Shahid Sadoughi University of Medical Sciences; Yazd; Iran
| | - Mehdi Ghandi
- School of Chemistry; University College of Science, University of Tehran; Tehran; Iran
| | - Alireza Foroumadi
- Department of Medicinal Chemistry; Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences; Tehran; Iran
| | - Abbas Shafiee
- Department of Medicinal Chemistry; Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences; Tehran; Iran
| |
Collapse
|
54
|
Hu C, Liu SJ, Cui LB, Xu HL, Wang TY, Li S, Lin HQ, Chicheong Wan D. Design, Synthesis, and Biological Evaluation of 7H-Thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives as Dual Binding Site Acetylcholinesterase Inhibitors. HETEROCYCLES 2013. [DOI: 10.3987/com-13-12820] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|